South Shore Capital Advisors

Position in NVS — Novartis AG

CIK 1852993 COHASSET, MA

Position in NVS

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$449,786

-$4,102,622 QoQ

Shares Held

2,870

-90.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.40%

of 13F equity value

Holder Rank

#935

of 1,603 holders

Holding Since

Dec 2020

4 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

South Shore Capital Advisors holds $5,027,059 across 5 Drug Manufacturers - General names. NVS ranks #3 (8.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	13,605	$3,455,261
2	LLY	ELI LILLY & Co	387	$464,179
3	NVS	Novartis AG This page	2,870	$449,786
4	MRK	Merck & Co., Inc.	3,498	$449,493
5	PFE	Pfizer Inc	8,652	$208,340

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$449,786	2,870	-90.4%	Shares	Sole	2026-07-30
2026-03-31	$4,552,408	29,803	+552.9%	Shares	Sole	2026-04-28
2025-12-31	$629,376	4,565	+59.4%	Shares	Sole	2026-01-21
2020-12-31	$270,353	2,863	—	Shares	Sole	2021-04-13
No filing history on record for this holder in this stock.